Cargando…

Classic and Follicular Variant of Papillary Thyroid Microcarcinoma: 2 Different Phenotypes Beyond Tumor Size

CONTEXT: Despite the wide revision of current guidelines, the management of papillary thyroid microcarcinoma (mPTC) still has to be decided case by case. There is conflicting evidence about the role of more frequent histological subtypes, and no data about potential differences at presentation. OBJE...

Descripción completa

Detalles Bibliográficos
Autores principales: Sparano, Clotilde, Rotondi, Mario, Verdiani, Valentina, Brunori, Paolo, Castiglione, Francesca, Bartoli, Caterina, Perigli, Giuliano, Badii, Benedetta, Vezzosi, Vania, Simontacchi, Gabriele, Livi, Lorenzo, Antonuzzo, Lorenzo, Maggi, Mario, Petrone, Luisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664971/
https://www.ncbi.nlm.nih.gov/pubmed/36397778
http://dx.doi.org/10.1210/jendso/bvac157
_version_ 1784831200030883840
author Sparano, Clotilde
Rotondi, Mario
Verdiani, Valentina
Brunori, Paolo
Castiglione, Francesca
Bartoli, Caterina
Perigli, Giuliano
Badii, Benedetta
Vezzosi, Vania
Simontacchi, Gabriele
Livi, Lorenzo
Antonuzzo, Lorenzo
Maggi, Mario
Petrone, Luisa
author_facet Sparano, Clotilde
Rotondi, Mario
Verdiani, Valentina
Brunori, Paolo
Castiglione, Francesca
Bartoli, Caterina
Perigli, Giuliano
Badii, Benedetta
Vezzosi, Vania
Simontacchi, Gabriele
Livi, Lorenzo
Antonuzzo, Lorenzo
Maggi, Mario
Petrone, Luisa
author_sort Sparano, Clotilde
collection PubMed
description CONTEXT: Despite the wide revision of current guidelines, the management of papillary thyroid microcarcinoma (mPTC) still has to be decided case by case. There is conflicting evidence about the role of more frequent histological subtypes, and no data about potential differences at presentation. OBJECTIVE: Our aim was to compare the phenotype of the 2 most frequent mPTC variants, namely, classical papillary thyroid microcarcinoma (mPTCc) and the follicular variant of papillary thyroid microcarcinoma (mFVPTC) . METHODS: Retrospective observational study, from January 2008 to December 2017 of a consecutive series of patients with mPTCc and mFVPTC. All cases were classified according to the 2015 American Thyroid Association (ATA) risk classification. Clinical and preclinical features of mPTCc and mFVPTC at diagnosis were collected. The comparison was also performed according to the incidental/nonincidental diagnosis and differences were verified by binary logistic analysis. RESULTS: In total, 235 patients were eligible for the analysis (125 and 110 mPTCc and mFVPTC, respectively). Compared with mPTCc, mFVPTCs were more often incidental and significantly smaller (4 vs 7 mm) (P < .001 all), possibly influenced by the higher rate of incidental detection. mFVPTC and incidental (P < .001 both) tumors were significantly more often allocated within the low-risk class. A logistic regression model, with ATA risk class as the dependent variable, showed that both mFVPTC (OR 0.465 [0.235-0.922]; P = .028]) and incidental diagnosis (OR 0.074 [0.036-0.163]; P < .001) independently predicted ATA risk stratification. CONCLUSION: mFVPTC shows some differences in diagnostic presentation compared with mPTCc, and seems to retain a significant number of favorable features, including a prevalent onset as incidental diagnosis.
format Online
Article
Text
id pubmed-9664971
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-96649712022-11-16 Classic and Follicular Variant of Papillary Thyroid Microcarcinoma: 2 Different Phenotypes Beyond Tumor Size Sparano, Clotilde Rotondi, Mario Verdiani, Valentina Brunori, Paolo Castiglione, Francesca Bartoli, Caterina Perigli, Giuliano Badii, Benedetta Vezzosi, Vania Simontacchi, Gabriele Livi, Lorenzo Antonuzzo, Lorenzo Maggi, Mario Petrone, Luisa J Endocr Soc Clinical Research Article CONTEXT: Despite the wide revision of current guidelines, the management of papillary thyroid microcarcinoma (mPTC) still has to be decided case by case. There is conflicting evidence about the role of more frequent histological subtypes, and no data about potential differences at presentation. OBJECTIVE: Our aim was to compare the phenotype of the 2 most frequent mPTC variants, namely, classical papillary thyroid microcarcinoma (mPTCc) and the follicular variant of papillary thyroid microcarcinoma (mFVPTC) . METHODS: Retrospective observational study, from January 2008 to December 2017 of a consecutive series of patients with mPTCc and mFVPTC. All cases were classified according to the 2015 American Thyroid Association (ATA) risk classification. Clinical and preclinical features of mPTCc and mFVPTC at diagnosis were collected. The comparison was also performed according to the incidental/nonincidental diagnosis and differences were verified by binary logistic analysis. RESULTS: In total, 235 patients were eligible for the analysis (125 and 110 mPTCc and mFVPTC, respectively). Compared with mPTCc, mFVPTCs were more often incidental and significantly smaller (4 vs 7 mm) (P < .001 all), possibly influenced by the higher rate of incidental detection. mFVPTC and incidental (P < .001 both) tumors were significantly more often allocated within the low-risk class. A logistic regression model, with ATA risk class as the dependent variable, showed that both mFVPTC (OR 0.465 [0.235-0.922]; P = .028]) and incidental diagnosis (OR 0.074 [0.036-0.163]; P < .001) independently predicted ATA risk stratification. CONCLUSION: mFVPTC shows some differences in diagnostic presentation compared with mPTCc, and seems to retain a significant number of favorable features, including a prevalent onset as incidental diagnosis. Oxford University Press 2022-10-13 /pmc/articles/PMC9664971/ /pubmed/36397778 http://dx.doi.org/10.1210/jendso/bvac157 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Clinical Research Article
Sparano, Clotilde
Rotondi, Mario
Verdiani, Valentina
Brunori, Paolo
Castiglione, Francesca
Bartoli, Caterina
Perigli, Giuliano
Badii, Benedetta
Vezzosi, Vania
Simontacchi, Gabriele
Livi, Lorenzo
Antonuzzo, Lorenzo
Maggi, Mario
Petrone, Luisa
Classic and Follicular Variant of Papillary Thyroid Microcarcinoma: 2 Different Phenotypes Beyond Tumor Size
title Classic and Follicular Variant of Papillary Thyroid Microcarcinoma: 2 Different Phenotypes Beyond Tumor Size
title_full Classic and Follicular Variant of Papillary Thyroid Microcarcinoma: 2 Different Phenotypes Beyond Tumor Size
title_fullStr Classic and Follicular Variant of Papillary Thyroid Microcarcinoma: 2 Different Phenotypes Beyond Tumor Size
title_full_unstemmed Classic and Follicular Variant of Papillary Thyroid Microcarcinoma: 2 Different Phenotypes Beyond Tumor Size
title_short Classic and Follicular Variant of Papillary Thyroid Microcarcinoma: 2 Different Phenotypes Beyond Tumor Size
title_sort classic and follicular variant of papillary thyroid microcarcinoma: 2 different phenotypes beyond tumor size
topic Clinical Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664971/
https://www.ncbi.nlm.nih.gov/pubmed/36397778
http://dx.doi.org/10.1210/jendso/bvac157
work_keys_str_mv AT sparanoclotilde classicandfollicularvariantofpapillarythyroidmicrocarcinoma2differentphenotypesbeyondtumorsize
AT rotondimario classicandfollicularvariantofpapillarythyroidmicrocarcinoma2differentphenotypesbeyondtumorsize
AT verdianivalentina classicandfollicularvariantofpapillarythyroidmicrocarcinoma2differentphenotypesbeyondtumorsize
AT brunoripaolo classicandfollicularvariantofpapillarythyroidmicrocarcinoma2differentphenotypesbeyondtumorsize
AT castiglionefrancesca classicandfollicularvariantofpapillarythyroidmicrocarcinoma2differentphenotypesbeyondtumorsize
AT bartolicaterina classicandfollicularvariantofpapillarythyroidmicrocarcinoma2differentphenotypesbeyondtumorsize
AT perigligiuliano classicandfollicularvariantofpapillarythyroidmicrocarcinoma2differentphenotypesbeyondtumorsize
AT badiibenedetta classicandfollicularvariantofpapillarythyroidmicrocarcinoma2differentphenotypesbeyondtumorsize
AT vezzosivania classicandfollicularvariantofpapillarythyroidmicrocarcinoma2differentphenotypesbeyondtumorsize
AT simontacchigabriele classicandfollicularvariantofpapillarythyroidmicrocarcinoma2differentphenotypesbeyondtumorsize
AT livilorenzo classicandfollicularvariantofpapillarythyroidmicrocarcinoma2differentphenotypesbeyondtumorsize
AT antonuzzolorenzo classicandfollicularvariantofpapillarythyroidmicrocarcinoma2differentphenotypesbeyondtumorsize
AT maggimario classicandfollicularvariantofpapillarythyroidmicrocarcinoma2differentphenotypesbeyondtumorsize
AT petroneluisa classicandfollicularvariantofpapillarythyroidmicrocarcinoma2differentphenotypesbeyondtumorsize